Log In
BCIQ
Print this Print this
 

BVA-601

  Manage Alerts
Collapse Summary General Information
Company Biovista Inc.
DescriptionRepositioned epilepsy drug
Molecular Target Histamine H1 receptor (HRH1)
Mechanism of ActionHistamine H1 receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationEpilepsy
Indication DetailsTreat epilepsy
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today